@lisabodei

Nuclear Medicine physician, theranostics specialist and researcher @MSKCancerCenter. Tweets and views are my own.

 Manhattan, NY
mskcc.org/cancer-care/doctors/lisa-bodei
Joined October 2009
  • Tweets39
  • Following101
  • Followers390
1Media
Lisa Bodei, MD, PhD retweeted
SNMMI@SNM_MI22 Jun 2025
Pretty packed at the Theranostics in NETs session!
3
46
2,131
Lisa Bodei, MD, PhD retweeted
JNM@JournalofNucMed19 Mar 2025
Green nuclear medicine and theranostics: debate and discussion. ow.ly/pMGa50VgahK #NuclearMedicine #Theranostics #MolecularImaging @ProfKHerrmann
6
16
1,318
Lisa Bodei, MD, PhD retweeted
SNMMI@SNM_MI8 Mar 2025
“Being a woman in nuclear medicine comes with the responsibility to recruit, support, and empower more women in this field."
1
1
2
106
Lisa Bodei, MD, PhD retweeted
SNMMI@SNM_MI8 Mar 2025
"I believe that my identity as a woman in this discipline enhances the application of a well-rounded and multifaceted approach to scientific exploration.”
2
1
2
88
Lisa Bodei, MD, PhD retweeted
SNMMI@SNM_MI8 Mar 2025
"Women bring unconditional strength, support, and dedication to whatever role inspires them personally or professionally.”
1
3
302
Lisa Bodei, MD, PhD retweeted
SNMMI@SNM_MI8 Mar 2025
"My leadership journey has reinforced the power of visibility: 'You can't be what you can't see.' I hope my role inspires others to pursue leadership, even if they once doubted their place in this field.”
1
1
5
317
Lisa Bodei, MD, PhD retweeted
SNMMI@SNM_MI8 Mar 2025
Today is International Women's Day, and SNMMI celebrates all of the trailblazing women in the nuclear medicine field whose expertise, passion, and dedication contribute to the highest standards of patient care.
1
2
7
425
Lisa Bodei, MD, PhD retweeted
JNM@JournalofNucMed28 Feb 2025
Reflections on the demand for PSMA- and SSTR-targeted radiopharmaceutical therapies: Why we were wrong (and why we will be right eventually). ow.ly/T40950UYrU2 #RPTherapy #NuclearMedicine #Theranostics @CalaisJeremie @lisabodei @CzerninJohannes
5
11
686
Lisa Bodei, MD, PhD retweeted
SNMMI@SNM_MI24 Oct 2024
Join us for episode 6 of the JNM podcast. Moderator Ken Herrmann, MD is joined by Simron Singh, MD and Lisa Bodei, MD, PhD to discuss NETTER-2, the first trial to examine radioligand therapy as a first-line therapy for cancers. Full episode here: youtu.be/whHhKf5fY8I
1
7
23
1,935
The hard copies of "Radiopharmaceutical Therapy" have arrived! Managed to get a pic with my Co-Editors…. The book really is the perfect stocking filler @lisabodei @TheZeglisLab
3
7
1
55
3,328
Thank you, Jason!!! Such a fantastic endeavor! Without you and Brian it would never have been possible
Jason Lewis Radiochem MSK@LewisLabMSKCC20 Nov 2023
It’s out!!! A huge thank you to all the contributors. Such a pleasure doing this with Professors @lisabodei and @TheZeglisLab. This book covers amazing the field of radiopharmaceutical therapy and is a real page turner. The perfect stocking filler 😀 doi.org/10.1007/978-3-031-39…

Radiopharmaceutical Therapy

link.springer.com
2
10
1,528
Coming in the fall 2023. So proud to have been a part of this fantastic endeavor! Everything about RPT. @LewisLabMSKCC @TheZeglisLab
Jason Lewis Radiochem MSK@LewisLabMSKCC30 Jun 2023
Coming to a bookstore near you in the Fall 2023. A super comprehensive guide to RPT. @lisabodei @TheZeglisLab
7
51
2,569
Lisa Bodei, MD, PhD retweeted
Thomas Hope@thomashopemd24 Jun 2023
We will also have a tumor board focused on clinical applications of PSMA-targeted radioligand therapy. What an amazing panel including @morr316 @lisabodei @TubaKendi @CalaisJeremie. See what people think of cases like this. Looking forward to seeing everyone bright and early!
4
20
1,298
Lisa Bodei, MD, PhD retweeted
SNMMI@SNM_MI12 Jun 2023
New Guideline Alert! Joint #SNMMI #EANM guideline for Lu-177 PSMA-targeted therapy will help practitioners select high-potential patients and prepare for clinical management. Thanks @EANM_NucMed! ow.ly/g7Ls50OKN8q #NuclearMedicine #RPTherapy #ProstateCancer
23
1
50
7,373
Lisa Bodei, MD, PhD retweeted
Thomas Hope@thomashopemd9 Jun 2023
Excited to announce the release of the @SNM_MI consensus statement on PSMA RLT. We attempted to wrangle with a number of difficult questions about how to use PSMA RLT in clinical practice. Check it out at: jnm.snmjournals.org/content/…
2
28
4
91
10,374
Amazing Keynote by @lisabodei before tonight’s opening ceremony #ISRS2023
1
6
448
Panelists are Dr.(s) Tara Masten, @CaterinaRamogi1, Danielle Vugts, and @lisabodei!
1
3
316
1. For the first @SNMMI_CIC case, @lisabodei from @MSKCancerCenter presents a case of #PSMARLT where FDG PET, post-treatment SPECT and MRI all play a role in understanding response. Please watch the full video at bit.ly/3Bw5kDm.
2
4
14
1,349
A study published in @JournalofNucMed and led by @lisabodei and Heiko Schöder found that blood-based biomarkers accurately predict neuroendocrine tumor response to radiopharmaceutical therapy. This study was selected as the featured article of the month: bit.ly/40YblEd
2
10
37
4,921
Lisa Bodei, MD, PhD retweeted
JNM@JournalofNucMed10 Apr 2023
Using blood-based #biomarkers to determine the efficacy of ¹⁷⁷Lu-DOTATATE in #NeuroendocrineTumors. ow.ly/4PAF50NAttU #NuclearMedicine #MedicalResearch #NETCancer @lisabodei @DianeReidyLagun @LabKrebs @amauguen @DrRichardDo
13
24
3,235
Load more